Characteristics and Outcomes of Patients Deferred for TAVR Because of COVID-19

This cohort study examines the characteristics and outcomes of patients for whom transcatheter aortic valve replacement (TAVR) was deferred because of the coronavirus disease 2019 (COVID-19) pandemic.

Read the full article here

Related Articles